Ignite Creation Date:
2025-12-24 @ 7:18 PM
Ignite Modification Date:
2026-03-21 @ 3:44 AM
Study NCT ID:
NCT03848403
Status:
TERMINATED
Last Update Posted:
2022-11-30
First Post:
2019-02-19
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Ixekizumab in Healthy Participants
Sponsor:
Eli Lilly and Company
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Healthy | View |
Keywords: